ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 85 filers reported holding ENZO BIOCHEM INC in Q4 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $92,000 | +12.2% | 26,010 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $82,000 | -7.9% | 26,010 | 0.0% | 0.00% | -25.0% |
| Q1 2021 | $89,000 | +34.8% | 26,010 | 0.0% | 0.00% | +33.3% |
| Q4 2020 | $66,000 | +20.0% | 26,010 | -0.8% | 0.00% | 0.0% |
| Q3 2020 | $55,000 | -6.8% | 26,210 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $59,000 | – | 26,210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |